GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:
Vitrolife (STO:VITR) is entering into a collaboration agreement with ParentPlus LLC, with the aim of developing new products for IUI (Intra-Uterine Insemination, artificial insemination).
Vitrolife (STO:VITR) is entering into a collaboration agreement with ParentPlus LLC, with the aim of developing new products for IUI (Intra-Uterine Insemination, artificial insemination).